How does methyldopa influence treatment outcomes in hypertensive patients with diabetic nephropathy and what are its effects on renal protection?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa reduces blood pressure in hypertensive diabetic nephropathy patients, improving renal outcomes by decreasing proteinuria and slowing renal function decline.